The latest Sustainability and CSR Reports all in one place

Multinational healthcare group sanofi-aventis has published its 2009 corporate social responsibility report at:
http://ethicalperformance.com/reports/links/sanofiaventiscsrreport09

The 74-page document, which covers 2009 activity, is entitled ‘Acting ethically and responsibly for the patient’.  Available on the Paris-based company’s website publication page, for the first time the report is available in electronic format only, enriched with videos and animations.

The report includes interviews with chief executive Christopher A. Viehbacher and senior vice president of corporate social responsibility Gilles Lhernould as well as setting out the Group’s overall CSR strategy.  The document identifies challenges, establishes priorities for the company and considers the performance of sanofi-aventis across the four key strands of its CSR activity: Patient 21, Ethics 21, People 21 and Planet 21.

Some key headline achievements revealed in the report include:

· Patient 21 – 10,000 lives were saved last year, thanks to sanofi-aventis drugs to treat sleeping sickness, with 140,000 lives saved since the inception of the company’s partnership with the Drugs for Neglected Diseases initiative;

· Ethics 21 – the company’s Responsible Purchasing Program, which is designed to improve awareness among Group suppliers of good social and environmental practices (and monitors their compliance with them), had been implemented in 29 countries by the end of 2009;

· People 21 – sanofi-aventis continued to expand the recruitment and retention of people with disabilities – between 2008 and 2009, the Group as a whole increased the number of individuals falling into this category by 8 per cent; and,

· Planet 21 is the key driver in sanofi-aventis’s commitment to sustainability and minimising its carbon footprint, and as such includes advances such as a commitment to reduce water usage -specific initiatives to improve the efficiency of water utilization achieved a decrease in water use across the Group of two per cent in 2009.

Topics covered in the report have been produced in response to requests from external stakeholders including patients, healthcare professionals, NGOs and governments. In addition, a selection of key report data has been audited by PriceWaterhouseCoopers and Ernst & Young.  Sanofi-aventis says the move ‘is an early demonstration of the renewed vigour with which we are embracing CSR and adapting our approach to meet the new opportunities before us’.

{ 0 comments }